News Sentiment

SOPH sentiment intelligence

Sophia Genetics SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 42 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 5.46 Week of 19 Jun 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

91/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+11.9% over one week, +11.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 91/100 classification
One-week reaction 11.9% Price confirming higher
Trend fit Trend active 11.9% over four weeks
Fair value 35.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 23
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
GuruFocus 4
MT Newswires 4
PR Newswire 3
Investing.com 2
MarketBeat 2
Market source 2
marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 4
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 42
Fidelity Direct company coverage

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

SOPHiA GENETICS has successfully closed a public offering of ordinary shares, raising $57.5 million. The offering included the full exercise of the underwriters' option to purchase additional shares, indicating strong market interest and investor confidence in the company. This c

Tone
Positive 77/100
Event
Market update
Published
20 Jun 2026 01:39
Source
Fidelity
MSN Direct company coverage

SOPHiA GENETICS prices $50M public offering at $4.75 per share

SOPHiA GENETICS has announced the pricing of a public offering of 10,526,316 ordinary shares at $4.75 per share, aiming to raise approximately $50 million before deductions. The offering is expected to close around June 21, 2024, and includes an option for underwriters to purchas

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 00:40
Source
MSN
GuruFocus Direct company coverage

Insider Sell: Zhenyu Xu Sells 4,000 Shares of Sophia Genetics SA

Zhenyu Xu, the Chief Scientific Officer of Sophia Genetics SA, sold 4,000 shares of the company on June 15, 2026, reducing his total holdings to 622,280 shares. This transaction is part of a larger trend of insider selling at Sophia Genetics SA, with 57 insider sells against only

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
GuruFocus
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) offers 10.53M shares; underwriters may add 1.58M

SOPHiA GENETICS has announced an offering of 10.526 million ordinary shares at $4.75 per share, aiming to raise gross proceeds of approximately $49.998 million. Underwriters have an option to purchase an additional 1.578 million shares. The net proceeds, estimated at $45.9 millio

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CSO sells 4,000 shares under 10b5-1 plan

SOPHiA GENETICS (SOPH) Chief Scientific Officer Xu Zhenyu sold 4,000 Ordinary Shares in an open-market transaction under a pre-arranged 10b5-1 trading plan. The shares were sold at a weighted average price of $5.0141, ranging from $4.90 to $5.13 per share. Following this transact

Tone
Negative 36/100
Event
Market update
Published
17 Jun 2026 20:09
Source
Stock Titan
Quantisnow Direct company coverage

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

SOPHiA GENETICS has announced a proposed public offering of its ordinary shares. This news was alerted to Quantisnow Plus members shortly after publication. Quantisnow, a market data and news platform, provides real-time alerts on various financial events including press releases

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 00:09
Source
Quantisnow
Stock Titan Direct company coverage

SOPHiA GENETICS (NASDAQ: SOPH) files supplement for share offering; $5.01 last trade

SOPHiA GENETICS has filed a preliminary prospectus supplement for an ordinary share offering, which includes a 30-day option for underwriters to purchase additional shares. The company reported 71,790,366 ordinary shares outstanding as of March 31, 2026, with a last reported Nasd

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

SOPHiA GENETICS plans new stock sale with option for 15% more shares

SOPHiA GENETICS (Nasdaq: SOPH) announced a proposed underwritten public offering of its ordinary shares, with an option for underwriters to purchase an additional 15% of shares. All shares will be newly issued by the company, and the offering's size, price, and timing are subject

Tone
Negative 40/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Stock Titan
Investing.com Direct company coverage

SOPHiA GENETICS stock falls on share offering announcement

SOPHiA GENETICS SA (NASDAQ:SOPH) shares fell in after-hours trading after the company announced a proposed underwritten public offering of its ordinary shares. The healthcare technology company plans to sell ordinary shares, with an option for underwriters to purchase an addition

Tone
Negative 28/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Investing.com
GuruFocus Direct company coverage

Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA

Philippe Menu, Chief Medical Officer of Sophia Genetics SA (SOPH), sold 5,000 shares on June 12, 2026, reducing his total holdings to 245,780 shares. This transaction is part of a trend for Sophia Genetics, which has seen 1 insider buy compared to 56 insider sells over the past y

Tone
Negative 37/100
Event
Market update
Published
15 Jun 2026 23:39
Source
GuruFocus
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under Rule 10b5-1 plan

SOPHiA GENETICS SA's Chief Medical Officer, Philippe Menu, sold 5,000 Ordinary Shares in an open-market transaction at a weighted average price of $4.9504 per share. This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was scheduled in ad

Tone
Negative 40/100
Event
Market update
Published
15 Jun 2026 20:10
Source
Stock Titan
GuruFocus Direct company coverage

Insider Sell Alert: Jurgi Camblong Sells 8,500 Shares of Sophia Genetics SA (SOPH)

Jurgi Camblong, CEO of Sophia Genetics SA (SOPH), sold 8,500 shares of the company on June 10, 2026, bringing his total holdings to 3,620,995 shares. Sophia Genetics, specializing in AI-driven data analysis for healthcare, has seen significantly more insider selling than buying o

Tone
Negative 36/100
Event
Market update
Published
12 Jun 2026 10:10
Source
GuruFocus
MarketBeat Direct company coverage

Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

SOPHiA GENETICS CEO Jurgi Camblong sold 8,500 shares of SOPH stock on June 10th for $44,540, following several similar transactions in March and April. This sale reduces his direct ownership by 0.23% to 3,620,995 shares, valued at approximately $18.97 million. The company's stock

Tone
Neutral 50/100
Event
Market update
Published
11 Jun 2026 21:36
Source
MarketBeat
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CEO sells 8,500 shares under 10b5-1 plan

SOPHiA GENETICS SA CEO Jurgi Camblong sold 8,500 Ordinary Shares at a weighted average price of $5.2354 per share. The sale was executed under a Rule 10b5-1(c) trading plan. Following this transaction, Camblong directly holds 3,620,995 shares.

Tone
Negative 38/100
Event
Market update
Published
11 Jun 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

SOPHiA GENETICS has confirmed leadership changes ahead of its 2026 Annual General Meeting. Ross Muken will become CEO on July 1, 2026, and co-founder Dr. Jurgi Camblong is nominated for election as Chairman of the Board. This transition aims to provide strategic continuity and le

Tone
Positive 71/100
Event
Market update
Published
10 Jun 2026 12:10
Source
Stock Titan
Market source Direct company coverage

Insider Spends US$99k Buying More Shares In SOPHiA GENETICS

SOPHiA GENETICS' Executive VP & CFO, George Cardoza, recently purchased US$99k worth of shares at US$4.95 each, increasing his holdings by 6.9%. This insider transaction, the largest in the past year, indicates confidence in the company despite it having made a loss in the last y

Tone
Positive 66/100
Event
Market update
Published
07 Jun 2026 14:47
Source
Market source
ChartMill Direct company coverage

SOPH News | SOPHIA GENETICS SA (NASDAQ:SOPH)

This article provides recent news and analysis for SOPHIA GENETICS SA (NASDAQ:SOPH), including financial results and strategic collaborations. Key updates mention mixed Q1 and Q4 2025 results with revenue beats, and significant partnerships for cancer testing. The stock is curren

Tone
Neutral 50/100
Event
Earnings
Published
05 Jun 2026 21:10
Source
ChartMill
Stock Titan Direct company coverage

[Form 4] SOPHiA GENETICS SA Insider Trading Activity

SOPHiA GENETICS SA's Chief Financial Officer, George Cardoza, purchased 20,000 Ordinary Shares at $4.95 each in an open-market transaction, increasing his direct holdings to 311,458 shares. This insider purchase, valued at $99,000, occurred during an open trading window and is hi

Tone
Positive 70/100
Event
Market update
Published
05 Jun 2026 20:10
Source
Stock Titan
Investing.com Direct company coverage

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth

BTIG has reiterated a Buy rating and an $8.00 price target on Sophia Genetics SA (NASDAQ:SOPH) after the company reported strong first-quarter revenue growth of 22%, surpassing analyst estimates. This growth was driven by increased volumes and the addition of 18 new customers, br

Tone
Positive 73/100
Event
Analyst action
Published
05 Jun 2026 01:09
Source
Investing.com